摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl (E,R)-5-hydroxy-3-oxo-7-phenylhept-6-enoate | 735287-46-4

中文名称
——
中文别名
——
英文名称
ethyl (E,R)-5-hydroxy-3-oxo-7-phenylhept-6-enoate
英文别名
ethyl (E,5R)-5-hydroxy-3-oxo-7-phenylhept-6-enoate
ethyl (E,R)-5-hydroxy-3-oxo-7-phenylhept-6-enoate化学式
CAS
735287-46-4
化学式
C15H18O4
mdl
——
分子量
262.306
InChiKey
NWNVDMRKXHDQDL-XEHSLEBBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    446.1±45.0 °C(Predicted)
  • 密度:
    1.150±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    19
  • 可旋转键数:
    8
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    63.6
  • 氢给体数:
    1
  • 氢受体数:
    4

SDS

SDS:8e38b8cd90e71f57cb4f876146767e1c
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Chemoenzymatic synthesis of enantiomerically enriched kavalactones
    作者:Ahmed Kamal、Tadiparthi Krishnaji、G.B. Ramesh Khanna
    DOI:10.1016/j.tetlet.2006.09.155
    日期:2006.12
    methyl-3-hydroxy-5-phenylpentanoate and (6E)-ethyl 5-hydroxy-3-oxo-7-phenylhept-6-enoate is described in high enantiomeric excess and good yields. The effect of different lipases in different solvents has been screened using different acylating agents. This protocol has been extended for the preparation of enantiomerically pure biologically important kavalactones.
    甲基-3-羟基-5-苯基戊和(6的脂肪酶介导的动力学拆分ë) -乙基-5-羟基-3-氧代-7-苯基庚-6-烯酸甲酯在高对映体过量和良好的产率进行说明。已经使用不同的酰化剂筛选了不同脂肪酶在不同溶剂中的作用。该方案已被扩展用于制备对映体纯的生物学上重要的卡伐内酯。
  • Versatile Asymmetric Synthesis of the Kavalactones:  First Synthesis of (+)-Kavain
    作者:Thomas E. Smith、Mabel Djang、Alan J. Velander、C. Wade Downey、Kathleen A. Carroll、Sophie van Alphen
    DOI:10.1021/ol0493960
    日期:2004.7.1
    Three asymmetric pathways to the kavalactones have been developed. The first method is chiral auxiliary-based and utilizes aldol reactions of N-acetyl thiazolidinethiones followed by a malonate displacement/decarboxylation reaction. The second approach uses the asymmetric catalytic Mukaiyama additions of dienolate nucleophile equivalents developed by Carreira and Sato. Finally, tin-substituted intermediates, prepared by either of these routes, can serve as advanced general precursors of kavalactone derivatives via Pd(0)-catalyzed Stille couplings with aryl halides.
  • Total synthesis of cryptomoscatone F1 through an asymmetric aldol approach
    作者:Perla Ramesh、Atla Raju、Nitin W. Fadnavis
    DOI:10.1016/j.tetasy.2015.09.011
    日期:2015.12
    A stereoselective total synthesis of naturally occurring styryl lactone, cryptomoscatone F1 is described. A Mukaiyama asymmetric aldol reaction, Brown's asymmetric allylation, Maruoka asymmetric allylation, and cross metathesis were used as the key steps. (C) 2015 Elsevier Ltd. All rights reserved.
  • Total synthesis of (−)-diospongin A and (+)-cryptofolione via asymmetric aldol reaction
    作者:Rayala Naveen Kumar、H.M. Meshram
    DOI:10.1016/j.tetlet.2010.12.070
    日期:2011.3
    Stereoselective synthesis of two distinctive pyranone skeletons diospongin A and cryptofolione has been described based on an asymmetric aldol reaction starting from Chan’s diene. The synthetic strategy involves the enantioselective Mukaiyama aldol, diastereoselective reduction of δ-hydroxy-β-keto ester, a tandem sequence of deprotection, and intramolecular oxa-Michael reaction to obtain diospongin
    基于从Chan's二烯开始的不对称醛醇缩合反应,已经描述了两个独特的吡喃酮骨架双皂甙A和隐叶酮的立体选择性合成。合成策略包括对映选择性Mukaiyama羟醛,非对映选择性还原δ-羟基-β-酮酸酯,一连串的脱保护序列以及分子内的oxa-Michael反应以获得双桥皂苷A以及使用闭环易位反应形成不对称的烯丙基化和内酯形成获得隐氟利酮。
  • Application of the Cosford cross-coupling protocol for the stereoselective synthesis of (R)-(+)-goniothalamin, (R)-(+)-kavain and (S)-(+)-7,8-dihydrokavain
    作者:Gowravaram Sabitha、K. Sudhakar、J.S. Yadav
    DOI:10.1016/j.tetlet.2006.09.122
    日期:2006.11
    An efficient and versatile synthetic method has been developed and utilized for the stereoselective synthesis of (R)-(+)goniothalamin 1, (R)-(+)-kavain 2 and (S)-(+)-7,8-dihydrokavain 3. Application of the Cosford protocol and direct conversion of aldehydes to P-keto-esters are the key steps in our approach. (c) 2006 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(R)-斯替戊喷酯-d9 隐甲藻 苯酚,2-(1-氯-3-乙基-3-羟基-1-戊烯基)-,(E)- 苯甲醛甘油缩醛 苯(甲)醛,2-[(1E,3S,4S,5E)-3,4-二羟基-1,5-庚二烯-1-基]-6-羟基- 肉桂醇 稻瘟醇 烯效唑 烯效唑 烯唑醇 (E)-(S)-异构体 氯化2-[(4-氨基-2-氯苯基)偶氮]-1,3-二甲基-1H-咪唑正离子 戊基肉桂醇 咖啡酰基乙醇 反式-3,4,5-三甲氧基肉桂醇 alpha-苯乙烯基-4-吡啶甲醇 R-烯效唑 R-烯唑醇 6-甲基-1-(3,4-亚甲二氧基苯基)-1-庚烯-3-醇 5-甲基-1-(3,4,5-三甲氧基苯基)-1-己烯-3-醇 5-甲基-1-(1,3-苯并二氧戊环-5-基)-1-己烯-3-醇 4-苯基-3-丁烯-2-醇 4-羟基肉桂醇 4-羟基-6-苯基己-5-烯-2-酮 4-硝基肉桂醇 4-甲基-1-苯基戊-1-烯-3-醇 4-(4-硝基苯基)丁-3-烯-2-醇 4-(4-溴苯基)丁-3-烯-2-醇 4-(4,4-二甲基-3-羟基-1-戊烯基)邻苯二酚 4-(3-羟基丙烯基)-2,6-双(3-甲基-2-丁烯基)苯酚 4-(3-羟基丙-1-烯基)苯酚 4-(2-苯基乙烯基)庚-1,6-二烯-4-醇 4,4-二氯-5,5,5-三氟-1-苯基戊-1-烯-3-醇 4,4,5,5,5-五氟-1-苯基戊-1-烯-3-醇 3-苯基戊-2-烯-1,5-二醇 3-苯基丙-2-烯-1-醇 3-甲基肉桂醇 3-甲基-4-苯基丁-3-烯-2-醇 3-甲基-4-苯基丁-3-烯-1,2-二醇 3-甲基-1-苯基戊-1-烯-4-炔-3-醇 3-甲基-1-苯基戊-1-烯-3-醇 3-氯-4-氟-4-苯基丁-3-烯-2-醇 3-(4-甲基苯基)丙-2-烯-1-醇乙酸酯 3-(4-溴苯基)丙-2-烯-1-醇 3-(3-硝基苯基)丙-2-烯-1-醇 3-(3,5-二氟苯基)丙醇 3-(3,4-二氯苯基)丙-2-烯-1-醇 3-(3,4,5-三甲氧基苯基)-2-丙烯-1-醇 3-(2-溴苯基)丙-2-烯-1-醇 3-(2-氟苯基)丙-2-烯-1-醇 3-(2,4-二氯苯基)-2-丙烯-1-醇